A new study demonstrates that a first-of-its-kind platform using artificial intelligence (AI) could help clinicians and patients assess whether and how much an individual patient may benefit from a ...

The institute originally began reviewing Lynparza in this setting in 2018 but ended its review due to lack of evidence.

West Philadelphia native Fran Visco, who heads the National Breast Cancer Coalition, is feted at White House. When Fran Visco ...

At Allegheny General Hospital, a new pilot program is focusing on patients diagnosed with metastatic breast cancer. It's a ...

Phase 3 data support pyrotinib plus trastuzumab and docetaxel “as a well-established and effective treatment strategy,” according to Binghe Xu, MD.

"It's fantastic news that olaparib has been approved for use on the NHS in England, providing a second targeted treatment option for certain people with locally advanced or secondary breast cancer who ...

An MP has said she has been diagnosed with breast cancer for a second time. Labour MP for West Lancashire Ashley Dalton said ...

Breast Cancer Now said olaparib will be an ‘valuable alternative’ for patients with a certain type of secondary breast cancer.

Incredible” results from the PATINA trial suggested a new standard of care for HER2, ER-positive metastatic breast cancer.

Allegheny Health Network's Cancer Institute announced Wednesday the launch of a pilot program addressing the mental health ...

Allegheny Health Network's Cancer Institute announced Wednesday the launch of a pilot program addressing the mental health ...